In the MCC model, both CD4+ T cells (33.7 ± 12.2%) and CD8+ T cells (54.1 ± 16.4%) populations were identified in the iPDX peripheral blood (Fig 1C). The gene discussed is CD4; the disease is Merkel cell skin cancer.